Lentitek Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$973K
- Investors
-
9
Lentitek General Information
Description
Developer of gene therapies and gene-modified cell therapies designed to increase lentiviral production yields. The company's platform offers a novel promoter with a proprietary method for producing lentivirus that could improve and enhance the yield of lentiviral vectors, enabling healthcare providers to reduce production costs through triple transfection production.
Contact Information
Website
www.lentitek.comCorporate Office
- Floor 3, 1-4 Atholl Crescent
- Edinburgh EH3 8HA
- Scotland, United Kingdom
Corporate Office
- Floor 3, 1-4 Atholl Crescent
- Edinburgh EH3 8HA
- Scotland, United Kingdom
Lentitek Timeline
Lentitek Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 12-Aug-2026 | $973K | Completed | Startup | ||
| 5. Angel (individual) | 13-Feb-2025 | Completed | Startup | |||
| 4. Grant | 28-Aug-2024 | Completed | Startup | |||
| 3. Angel (individual) | 09-May-2023 | Completed | Startup | |||
| 2. Grant | 10-Jun-2022 | $100K | $54.8K | Completed | Startup | |
| 1. Angel (individual) | 13-Feb-2021 | $54.8K | $54.8K | Completed | Startup |
Lentitek Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 30,267 | $0.000013 | $11.87 | $11.87 | $11.87 | 11.18% | ||
| Ordinary | 47,050 | $0.000013 | $1.14 | $1.14 | $1.14 | 17.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lentitek Comparisons
Industry
Financing
Details
Lentitek Competitors (3)
One of Lentitek’s 3 competitors is Oxb, a Corporation company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxb | Corporation | Oxford, United Kingdom | ||||
| aTen Therapeutics | Venture Capital-Backed | Edinburgh, United Kingdom | ||||
| Antev | Formerly VC-backed | London, United Kingdom |
Lentitek Patents
Lentitek Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4684024-A1 | Expression construct | Pending | 22-Mar-2023 | ||
| JP-2026511127-A | Expression construct | Pending | 22-Mar-2023 | ||
| US-20260265777-A1 | Expression construct | Pending | 22-Mar-2023 | ||
| WO-2024194651-A1 | Expression construct | Inactive | 22-Mar-2023 | C12N15/86 |
Lentitek Signals
Lentitek Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Equity Gap | Angel Group | Minority | ||
| Old College Capital | Venture Capital | Minority | ||
| Orchard Venture Partners | Venture Capital | Minority | ||
| Scottish Enterprise | Growth/Expansion | Minority | ||
| Shancastle Investments | Corporation | Minority |
Lentitek FAQs
-
When was Lentitek founded?
Lentitek was founded in 2019.
-
Where is Lentitek headquartered?
Lentitek is headquartered in Edinburgh, United Kingdom.
-
What is the size of Lentitek?
Lentitek has 10 total employees.
-
What industry is Lentitek in?
Lentitek’s primary industry is Biotechnology.
-
Is Lentitek a private or public company?
Lentitek is a Private company.
-
What is the current valuation of Lentitek?
The current valuation of Lentitek is .
-
What is Lentitek’s current revenue?
The current revenue for Lentitek is .
-
How much funding has Lentitek raised over time?
Lentitek has raised $2.6M.
-
Who are Lentitek’s investors?
Equity Gap, Old College Capital, Orchard Venture Partners, Scottish Enterprise, and Shancastle Investments are 5 of 9 investors who have invested in Lentitek.
-
Who are Lentitek’s competitors?
Oxb, aTen Therapeutics, and Antev are competitors of Lentitek.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process